440 Collins Street
Level 10
Melbourne, VIC 3000
Australia
1300 301 874
https://www.firebrickpharma.com
Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full-time employees:
Firebrick Pharma Limited engages in the development and partnering of broad-spectrum antimicrobial spray for the treatment of common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.
Firebrick Pharma Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.